Dr. Sumant Ramachandra to advise the Company about the development of its revolutionary cancer treatmentLehi, UT, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Lehi, UT, February 27, 2025 (GLOBE NEWSWIRE) -- ...